Imunon, Inc. Revenue 2017–2022
Imunon, Inc. annual/quarterly revenue history and growth rate from 2017 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Imunon, Inc. revenue for the quarter ending September 30, 2022 was 125000, a 0.00% increase year-over-year.
- Imunon, Inc. revenue for the twelve months ending September 30, 2022 was 500000, a 0.00% increase year-over-year.
- Imunon, Inc. annual revenue for 2022 was 500000, a 0.00% increase from 2021.
- Imunon, Inc. annual revenue for 2021 was 500000, a 0.00% increase from 2020.
- Imunon, Inc. annual revenue for 2020 was 500000, a 0.00% increase from 2019.
- Imunon, Inc. annual revenue for 2019 was 500000.
Imunon, Inc. (IMNN) — Frequently Asked Questions
Imunon, Inc. (IMNN) is a publicly traded US company. It has a market capitalization of $14M. In fiscal 2022 it reported revenue of $500,000 and net income of -$36M. Explore IMNN's stock price, financial statements, earnings history, margins and key ratios below.
What is Imunon, Inc.'s market cap?
Imunon, Inc. (IMNN) has a market capitalization of $14M.
What is the IMNN stock price?
IMNN trades at $1.98 (-1.98% on the day).
How much revenue does Imunon, Inc. make?
Imunon, Inc. reported revenue of $500,000 in fiscal 2022.
Is IMNN profitable?
In fiscal 2022, Imunon, Inc. reported net income of -$36M.